Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
94
datasets available to search
ShareScore release 0.7.1
Dataset results
94 results for “clindamycin”
Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
ClinicalTrials.gov study NCT00823901. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
ClinicalTrials.gov study NCT01744730. IPD Sharing: Not stated. Countries: 1. Publications: 27.
Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne
ClinicalTrials.gov study NCT00776919. IPD Sharing: YES. Countries: 3. Publications: 1.
Clindamycin Once a Day in Septic Abortion
ClinicalTrials.gov study NCT02309346. IPD Sharing: YES. Countries: 1. Publications: 17.
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
ClinicalTrials.gov study NCT02005666. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris
ClinicalTrials.gov study NCT01915732. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Data from: Adjunctive clindamycin for cellulitis: clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis
Objective: To compare flucloxacillin with clindamycin to flucloxacillin alone for the treatment of limb cellulitis. Design: Parallel, double-blinded, randomised controlled trial. Setting: Emergency department attendances and general practice referrals within 20 hospitals in England. Interventions: Flucloxacillin, at a minimum of 500 mg 4 times per day for 5 days, with clindamycin 300 mg 4 times per day for 2 days given orally versus flucloxacillin given alone. Main outcome measures: The primary outcome was improvement at day 5. This was defined as being afebrile with either a reduction in affected skin surface temperature or a reduction in the circumference of the affected area. Secondary outcomes included resolution of systemic features, resolution of inflammatory markers, recovery of renal function, reduction in the affected area, decrease in pain, return to work or normal activities and the absence of increased side effects. Results: 410 patients were included in the trial. No significant difference was seen in improvement at day 5 for flucloxacillin with clindamycin (136/156, 87%) versus flucloxacillin alone (140/172, 81%)—OR 1.55 (95% CI 0.81 to 3.01), p=0.174. There was a significant difference in the number of patients with diarrhoea at day 5 in the flucloxacillin with clindamycin allocation (34/160, 22%) versus flucloxacillin alone (16/176, 9%)—OR 2.7 (95% CI 1.41 to 5.07), p=0.002. There was no clinically significant difference in any secondary outcome measures. There was no significant difference in the number of patients stating that they had returned to normal activities at the day 30 interview in the flucloxacillin with clindamycin allocation (99/121, 82%) versus flucloxacillin alone (104/129, 81%)—adjusted OR 0.90 (95% CI 0.44 to 1.84). Conclusions: The addition of a short course of clindamycin to flucloxacillin early on in limb cellulitis does not improve outcome. The addition of clindamycin doubles the likelihood of diarrhoea within the first few days.
Treatment of Malaria in Gabon With Fosmidomycin-Clindamycin
ClinicalTrials.gov study NCT00217451. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Clindamycin-trimethoprim/Sulfamethoxazole for PCP After Solid Organ Transplantation Population.
ClinicalTrials.gov study NCT04328688. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris
ClinicalTrials.gov study NCT02721173. IPD Sharing: NO. Countries: 1. Publications: 11.
The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS
ClinicalTrials.gov study NCT00000717. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk Pregnancies
ClinicalTrials.gov study NCT01722708. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjunctive Clindamycin for Cellulitis: C4C Trial.
ClinicalTrials.gov study NCT01876628. IPD Sharing: YES. Countries: 1. Publications: 1.
Clindamycin Versus Amoxicillin With Clavulanic Acid in Prevention of Early Dental Implants Failure
ClinicalTrials.gov study NCT04980170. IPD Sharing: NO. Countries: 1. Publications: 4.
Clindamycin to Reduce Preterm Birth in a Low Resource Setting
ClinicalTrials.gov study NCT01800825. IPD Sharing: Not stated. Countries: 1. Publications: 15.
A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS
ClinicalTrials.gov study NCT00000640. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy of Fosmidomycin-Clindamycin for Treating Malaria in Gabonese Children
ClinicalTrials.gov study NCT00214643. IPD Sharing: Not stated. Countries: 1. Publications: 13.
A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS
ClinicalTrials.gov study NCT00000674. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris
ClinicalTrials.gov study NCT03615768. IPD Sharing: NO. Countries: 1. Publications: 1.
PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children
ClinicalTrials.gov study NCT02475876. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.